Reversal of Subarachnoid Hemorrhage-induced Vasoconstriction with an Endothelin Receptor Antagonist
- 1 January 1994
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 34 (1) , 108-113
- https://doi.org/10.1227/00006123-199401000-00016
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Reversal of endothelin-1-induced vasoconstriction by nifedipine in human resistance vessels in vivo in healthy subjectsThe American Journal of Cardiology, 1992
- Vasoconstrictor effects of endothelin-1 on myocardium microcirculation studied by the langendorff perfusion method: Differential sensitivities among microvesselsMicrovascular Research, 1992
- Effect of endothelin on normal and diseased human coronary arteriesEuropean Journal of Clinical Investigation, 1992
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Endothelin: a potential modulator of cerebral vasospasmEuropean Journal of Pharmacology, 1990
- Effects of endothelin on the coronary vascular bed in open-chest dogs.Circulation Research, 1989
- The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhageNeurological Research, 1989
- Endothelin and the production of cerebral vasospasm in dogsBiochemical and Biophysical Research Communications, 1989
- ENDOTHELIN: AN IMPORTANT FACTOR IN ACUTE RENAL FAILURE?The Lancet, 1988